Netflix, Inc. (NFLX) was reiterated a ‘Buy’ by Stifel analysts on Monday. The firm also raised its price target on the stock to $143 from $128 noting Netflix is becoming synonymous with digital video streaming, much like Amazon.com (AMZN) is to Retail and Google (GOOG), (GOOGL) is to Search. NFLX’s price target was also raised to $161 at Topeka Capital Markets.
On valuation measures, Netflix shares are currently priced at 277.24x this year’s forecasted earnings, compared to the industry’s 16.19x earnings multiple. Ticker has a forward P/E of 411.87 and t-12 price-to-sales ratio of 8.61. EPS for the same period is $0.45.
In the past 52 weeks, shares of Los Gatos, California-based company have traded between a low of $45.08 and a high of $129.29 and are now at $123.65. Shares are 153.11% since the beginning of the year.
Analysts at Raymond James upgraded their rating on the shares of NeoPhotonics Corporation (NPTN). In a research note published on Monday, the firm lifted the name with a ‘Strong Buy‘ from ‘Outperform‘ rating.
Currently there are 2 analysts that rate NPTN a ‘Buy‘, 1 rates it a ‘Hold‘ whereas no analyst rates it a ‘Sell‘. NPTN has a median Wall Street price target of $11.00 with a high target of $13.00.
Twitter, Inc. (TWTR) was raised to ‘Buy‘ from ‘Neutral‘ and it was given a $35 price target at Monness Crespi & Hardt on Monday. Firm believes with the stock back to nearly the IPO price of $26, now is the time to pivot to a positive outlook on the name.
TWTR is up $1.93 at $28.98 on heavy volume. Midway through trading Monday, 24 million shares of Twitter Inc. have exchanged hands as compared to its average daily volume of 23.39 million shares. The stock has ranged in a price between $27.82 to $29.05 after having opened the day at $28.08 as compared to the previous trading day’s close of $27.04.
Over the past year, shares of San Francisco, Calif.-based microblogging service have traded between a low of $26.87 and a high of $55.99. Shares are down 37.12% year-over-year and 24.62% year-to-date.
In a report published Monday, Robert W. Baird analysts initiated coverage on Google Inc. (GOOGL) with a ‘Outperform‘ rating and $720 price target.
GOOGL is currently printing a normal trading volume with the issue trading 771K shares, compared to the average volume of 2.75 million. The stock began trading this morning at $667.09 to currently trade 0.24% lower from the prior days close of $664.39. On an intraday basis it has gotten as low as $660.23 and as high as $671.62.
Google shares have advanced 21.98% in the last 4 weeks and 21.03% in the past three months. Over the past 5 trading sessions the stock has gained 1.05%. The Mountain View California-based search giant, which is currently valued at $454.24 billion, has a median Wall Street price target of $750.00 with a high target of $805.00.
Google Inc. Cl A is up 16.19% year-over-year, compared with a 7.26% gain in the S&P 500.
In a report issued to clients Monday, Cowen analysts raised the price target on Aquinox Pharmaceuticals Inc. (AQXP) to $14 from $3.
Shares of Aquinox spiked as high as $55.75 Monday morning, bringing the stock up more than 3,000% since Thursday’s close of $1.79 – that’s not a typo. The catalyst for the massive gain came after Thursday’s positive results from secondary endpoints from phase 2 LEADERSHIP Trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis (BPS/IC).